Bluejay Diagnostics (BJDX) announced that the company’s Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1-for-50. The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on November 18, and the company’s common stock will open for trading on The Nasdaq Capital Market on a post-split basis on November 18 under the company’s existing trading symbol, “BJDX.” At such time, the company’s common stock will also commence trading with a new CUSIP number, 095633509.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.